about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyGenetically engineered mouse models of pancreatic adenocarcinomamiR-146a suppresses invasion of pancreatic cancer cellsAnti-neoplastic activity of two flavone isomers derived from Gnaphalium elegans and Achyrocline bogotensisAnti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algaeTargeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in miceInhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsUp-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells.Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and MetastasisMucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.Apoptotic pathways in pancreatic ductal adenocarcinomaTW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer.Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.DEPTOR has growth suppression activity against pancreatic cancer cells.A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1.Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer.Molecular predictors of gemcitabine response in pancreatic cancer.RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway.
P2860
Q22299231-0CF88197-E443-442F-B1EF-F459B0127095Q27002973-C6055D12-F7D5-4AEA-BF05-F94447D2F786Q28272101-E4A30C14-295B-4EEE-A130-D0B2ACA5C54FQ28480937-1AFA5D70-84BE-47B6-B882-0FF5E9E7001AQ28486199-C910577A-CCDA-4741-B40F-6DF62EAE3544Q28487437-F5DBB1B4-95E6-4DB1-8FE1-EC5619C9C9B7Q33714709-E0B2421C-C4D3-456F-A8A7-753AC79CD59AQ34021737-351814CD-9946-4652-B786-C6914A3506B5Q34199678-3DD8AD16-386B-47B7-86CD-9155C688CA4EQ35922334-983BC1AC-D7B4-4CF1-A49B-38D9B3C26B56Q36437150-4A1AB63C-8FA7-41D0-994D-C1A6B648D76BQ36835642-36B63375-DCA2-4C2C-B5D1-B4177911C115Q37154117-8DA446DF-6D40-4E9E-85D7-06C8221B363DQ37809242-AC721A82-E12B-4F53-A896-3BE7EB6B1F04Q38352184-84E1825A-1789-4529-9D39-32F2121DD466Q38924935-D46810A1-EDE0-4576-BB76-D3DBCF8C60BFQ38953653-62B42F2C-6048-4B0D-ACEE-E4303DF48ADCQ39165812-A3DA66E8-8192-4E24-A1E3-785C6C9F502BQ39250668-FB60E576-86DF-4E99-8CE8-705A0CDC313FQ40609648-9E1ABC05-6986-4EE9-A250-D332FFA5D0BBQ42553269-44CABA9D-B151-4E8E-9941-E976994F0E3DQ43199306-B9570A9F-95A5-4655-A633-A2B0A042C2DFQ55223095-81D9C4BE-36C5-41B5-887F-B4FAF4E510AE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
NF-kappaB in pancreatic cancer.
@ast
NF-kappaB in pancreatic cancer.
@en
type
label
NF-kappaB in pancreatic cancer.
@ast
NF-kappaB in pancreatic cancer.
@en
prefLabel
NF-kappaB in pancreatic cancer.
@ast
NF-kappaB in pancreatic cancer.
@en
P2093
P356
P1476
NF-kappaB in pancreatic cancer.
@en
P2093
Christian Schmidt
Douglas B Evans
Guido M Sclabas
Paul J Chiao
Shuichi Fujioka
P356
10.1385/IJGC:33:1:15
P577
2003-01-01T00:00:00Z